Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome.
Saved in:
| Title: | Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome. |
|---|---|
| Authors: | Cuisset, Thomas1,2,3 thomas.cuisset@ap-hm.fr, Cayla, Guillaume4, Quilici, Jacques1,2,3, Pankert, Mathieu1,2,3, Deharo, Pierre1,2,3, Bonnet, Guillaume1,2,3, Grosdidier, Charlotte2,3,5, Beguin, Shirley6, Morange, Pierre2,3,5, Bonnet, Jean-Louis1,2,3, Alessi, Marie-Christine2,3,5 |
| Source: | International Journal of Cardiology. Oct2013, Vol. 168 Issue 3, p2988-2989. 2p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
